Skip to main content

Featured

A Pricey Path to Residency: Trump Administration Unveils $1M Gold Card Visa

  The Trump administration has announced the launch of a new immigration initiative dubbed the Gold Card Visa , a program that grants residency to foreign nationals willing to invest $1 million. Marketed as a fast-track entry into the United States, the visa is designed to attract wealthy investors and entrepreneurs seeking long-term opportunities in the country. Officials describe the program as a way to boost economic growth by channeling foreign capital into American businesses and infrastructure. Critics, however, argue that the policy favors the ultra-rich while sidelining skilled workers and families who lack the financial means to participate. The Gold Card Visa is expected to generate debate over the balance between economic incentives and equitable access to immigration. Supporters see it as a pragmatic move to secure investment, while opponents warn it could deepen inequality in the immigration system.

article

Pharmacare in Canada: A Dream or a Reality?

 


The fate of Canada's pharmacare plan is uncertain as the federal government faces challenges in implementing a universal drug coverage program, even if a bill to create one passes in Parliament. Bill C-213, the Canada Pharmacare Act, aims to establish a national framework for pharmacare that would ensure all Canadians have access to prescription drugs based on their medical needs, not their ability to pay. 

However, the bill does not specify how the program would be funded, administered or negotiated with the provinces and territories, leaving many questions unanswered about the feasibility and cost-effectiveness of pharmacare. Some experts and stakeholders have expressed doubts about whether Ottawa has the political will, the constitutional authority and the fiscal capacity to deliver on its promise of pharmacare, especially in the wake of the COVID-19 pandemic that has strained the health care system and the public purse.

Comments